COVID-19 - January 25, 2021
New data about AdaptVac’s cVLP based SARS-CoV-2 subunit vaccine
AdaptVac has announced the publication of strong virus neutralization animal proof-of-concept data for its capsid virus like particle (cVLP) based SARS-CoV-2 subunit vaccine in Nature Communications. The vaccine elicited antibodies in mice which effectively prevented live SARS-CoV-2 virus from infecting and killing human cells in an in vitro assay. The project remains on track for […]
COVID-19 - January 19, 2021
Capitainer raises SEK 31 million
Swedish medtech start-up Capitainer has closed a share issue of SEK 31 million to roll out its new qDBS dried blood spot testing system. Led by Sciety the target was reached almost immediately after the pitch, primarily attracting both existing and new industry specialist investors. The investment comes as Capitainer anticipates a major increase in […]
COVID-19 - January 13, 2021
Nanobodies show promising effects against COVID-19 infection
Researchers have developed new small antibodies, nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells. In a new study, published in Science, researchers from Karolinska Institutet in collaboration with researchers at the University of Bonn in Germany and the Scripps Research Institute in California, show that a combined nanobody had a particularly good effect – even […]
COVID-19 - January 12, 2021
New in vitro study results about Pfizer/BioNTech’s COVID-19 vaccine
Pfizer and BioNTech have announced results from an in vitro study that shows the antibodies from people who have received their vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv. Variants of SARS-CoV-2 Rapidly spreading variants of SARS-CoV-2 […]
COVID-19 - January 10, 2021
Production and supply – A logistics challenge
The manufacturing, packaging and transportation of COVID-19 vaccines requires a smooth, effective and safe supply chain. Time is of the essence, and the pharma industry supply chain is facing big logistics challenges. In record time the global life science industry has been able to discover and develop one vaccine approved for full use, six vaccines […]
COVID-19 - January 7, 2021
AstraZeneca’s COVID-19 vaccine obtains emergency use authorization in India
AstraZeneca’s COVID-19 vaccine has been granted emergency use authorization in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the active immunization of adults. The approval in India is an important milestone as it will enable to supply India but also a large number of countries around the world. AstraZeneca has […]
